Skip to main content

Foresite Capital — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

130
Companies
$12.6B
Total invested
$127.7M
Avg. check
14
Industries
Biotechnology 9Health Care 7Pharmaceutical 5Therapeutics 5Medical Device 3Medical 3+8 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121–130 of 130
Gemini Therapeutics
February 2021

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Biopharma · Cambridge$95.0M Post Ipo Equity
EverlyWell
January 2021

EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.

Health Care · Austin$75.0M Secondary Market
Kira Pharmaceuticals
January 2021

Kira Pharmaceuticals is a Biotechnology Research Company.

Biotechnology · Hong Kong$53.5M Series B
SAGE Therapeutics
November 2020

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Biotechnology · Cambridge$650.0M Post Ipo Equity
Decibel Therapeutics
November 2020

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

Biotechnology · Cambridge$82.2M Series D
Turning Point Therapeutics
October 2020

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.

Biotechnology · San Diego$460.0M Post Ipo Equity
Aimmune Therapeutics
February 2020

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

Biotechnology · Brisbane$200.0M Post Ipo Equity
PACT Pharma
January 2020

Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.

Biotechnology · Hayward$75.0M Series C
10X Genomics
January 2020

10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.

Biotechnology · PleasantonPost Ipo Equity
Peloton Therapeutics
February 2019

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Biotechnology · Dallas$150.0M Series E

Where Foresite Capital invests

Biotechnology9
Health Care7
Pharmaceutical5
Therapeutics5
Medical Device3
Medical3

About Foresite Capital's portfolio

How many companies has Foresite Capital invested in?▸

Foresite Capital has invested in 130 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Foresite Capital invest in?▸

Foresite Capital's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical Device. The firm invests across 14 different industry categories.

What is Foresite Capital's largest investment?▸

Among tracked funding rounds, SAGE Therapeutics received $650.0M in a Post Ipo Equity round. Foresite Capital's total known invested capital is $12.6B.

What is the average investment size for Foresite Capital?▸

Foresite Capital's average investment size is $127.7M across its portfolio of 130 companies.

What are Foresite Capital's most recent investments?▸

Recent Foresite Capital portfolio additions include Gemini Therapeutics, EverlyWell, Kira Pharmaceuticals, SAGE Therapeutics, Decibel Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 130 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →